Novartis to Test Efficacy of Old Malaria Drug Against COVID-19 Novartis to Test Efficacy of Old Malaria Drug Against COVID-19
Swiss drugmaker Novartis AG said on Monday it will test the malaria drug hydroxychloroquine in a randomized trial to see if the much talked about medicine is actually effective against COVID-19.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
More News: COVID-19 | Hydroxychloroquine | Infectious Diseases | Intensive Care | Malaria | Switzerland Health